Hebei ChenGuang Pharmaceutical Co., Ltd. announced that it will receive CNY 81,000,000 in an equity round of funding on December 26, 2021. The transaction will include participation from existing investor ChenGuang Biotech Group Co., Ltd. Pursuant to the transaction, the registered capital of the company will increase from CNY 19,000,000 to CNY 100,000,000. The transaction has been approved at the 37th meeting of 4th directorate of the company's parent and does not require shareholder approval.